Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

OpenNIH

Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

NHLBI Program Project Applications (P01 Clinical Trials Optional)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)

Sep 25, 2026
Closes
View opportunity →
OpenNIH

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)

$350,000
Award ceiling
Sep 25, 2026
Closes
View opportunity →
OpenDOS

Strengthening Bosnia and Herzegovina’s Organized Crime Specialized Departments for Organized Crime Through Expert Advisory Support

$150,000
Total funding
Sep 28, 2026
Closes
View opportunity →
OpenFTA

FY26 Bus Safety, Accessibility, and Innovation Notice of Funding Opportunity

$10,000,000
Total funding
Sep 28, 2026
Closes
View opportunity →
OpenBLM

FY26 Bureau of Land Management Plant Conservation and Restoration Management - Bureau wide

$2,500,000
Total funding
Sep 28, 2026
Closes
View opportunity →
OpenUSDA

Coordinating Agricultural Development & Innovation (CADI) to enable America First Trade Wins in Europe, the South Caucasus and Central Asia

$997,500
Total funding
Sep 28, 2026
Closes
View opportunity →
OpenNIH

Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)

$10,000,000
Total funding
Sep 28, 2026
Closes
View opportunity →